This chapter examines the swiftly advancing domain of robotic platforms utilizing cell-free protein synthesis (CFPS) and other programmable cell-free biological mechanisms.
First-pass extracted concept
automated cell-free systems
Candidate: concept label1 source documents5 linked claims
Live refresh every 5sNext refresh in 5s
Aliases
robotic platforms utilizing cell-free protein synthesis
Evidence Snippets
Supporting Sources
Linked Claims
Cell-free systems offer less contamination risk, improved control over reaction variables, and faster response times than conventional cell-based approaches.
Quoted textsource-backed
Cell-free systems have substantial benefits compared to conventional cell-based approaches, such as less contamination risk, improved control over reaction variables, and expedited response times.
Key challenges for automated cell-free systems include standardization, development of more resilient and economical cell-free extracts, and incorporation of artificial intelligence and machine learning for experimental design and process optimization.
Quoted textsource-backed
Principal difficulties addressed encompass standardization, the creation of more resilient and economical cell-free extracts, and the incorporation of artificial intelligence and machine learning for enhanced experimental design and process optimization.
Integrating programmable cell-free systems with automation and robotics is expected to accelerate discovery, enable innovative biomaterials, and broaden access to advanced biotechnological tools and applications.
Quoted textsource-backed
The integration of cell-free system programmability with the accuracy and scalability of automation and robotics is set to expedite discovery, facilitate the development of innovative biomaterials, and broaden access to advanced biotechnological tools and applications.
Automated cell-free systems emphasize microfluidic devices, liquid handling robots, and integrated analytical platforms.
Quoted textsource-backed
This chapter offers a detailed examination of the design, functionalities, and constraints of automated cell-free systems, emphasizing technologies such as microfluidic devices, liquid handling robots, and integrated analytical platforms.
The properties of cell-free systems make them well suited for high-throughput screening, rapid prototyping of synthetic biology circuits, on-demand biomanufacturing, and point-of-care diagnostics.
Quoted textsource-backed
These attributes render them exceptionally appropriate for high-throughput screening, expedited prototyping of synthetic biology circuits, on-demand biomanufacturing, and point-of-care diagnostics.